Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...